4931
Study of GSK2862277 in Subjects Undergoing Oesophagectomy Surgery
Condition(s):Lung Injury, Acute and Respiratory Distress Syndrome, AdultLast Updated:October 27, 2020Terminated
5% Dextrose: 5409 Clinical Trials, Page 494 of 541
Hide Studies Not Open or Pending
4932
The eHealth Diabetes Remission Trial
Condition(s):Diabetes Mellitus, Type 2Last Updated:September 10, 2022Recruiting
4933
A Safety and Efficacy Study Comparing Naltrexone SR/Bupropion SR and Placebo in Obese Subjects With Type 2 Diabetes
Condition(s):Obesity; Overweight; Diabetes Mellitus, Type 2Last Updated:November 21, 2014Completed
4934
Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
Condition(s):Melanoma; NSCLC; Hepatocellular Carcinoma; Urothelial Cancer; Gastric Adenocarcinoma; HNSCC; Esophageal Adenocarcinoma; Microsatellite Instability-High Solid Malignant TumorLast Updated:July 17, 2023Recruiting
4935
Dulce Digital 2.0 – Innovative Diabetes Self-Management in the Digital Age
Condition(s):Diabetes Type 2Last Updated:May 16, 2023Recruiting
4936
A Research Study to Compare Two Doses of Semaglutide Taken Once Weekly in People With Type 2 Diabetes
Condition(s):Diabetes Mellitus, Type 2Last Updated:February 13, 2023Completed
4937
SGLT-2 Inhibitors in Prevention of Post-procedural Renal and Cardiovascular Complications aFter PCI Among Patients With Diabetes Mellitus and Coronary Artery Disease: a Prospective, Randomized, Pilot Study (SAFE-PCI)
Condition(s):Diabetes Mellitus, Type 2; Coronary Artery Disease; Acute Kidney InjuryLast Updated:September 8, 2021Unknown status
4938
Comparison of Fasiglifam (TAK-875) to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Condition(s):Glycemic ControlLast Updated:June 2, 2016Terminated
4939
Effect of Pre-emptive Intravenous Immunoglobulin (IVIG) on the Incidence of Septic Episodes in Pediatric Burn Patients
Condition(s):Burn ShockLast Updated:November 15, 2022Completed
4940
A Deep Learning Method to Evaluate QT on Ribociclib
Condition(s):Breast Cancer; RibociclibLast Updated:September 6, 2023Recruiting